Tag: circulatingTumorCell

Circulating tumor cell: A disseminated cancer cell found in the blood of a patient with a solid tumor, representing a cell shed into the vasculature from a primary tumor or metastasis.

Articles

Morphine during surgery might increase risk of metastasis

News

02/21/16: HDL from BC patients with type 2 diabetes can promote metastasis

Studies

Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer Cite
Xie P, Zhang X, Liu T, Song Y, Zhang Q, Wan D, et al. Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer. Discover Oncology. Springer Science and Business Media LLC; 2024; 15 10.1007/s12672-024-01663-0
Cancer treatments as paradoxical catalysts of tumor awakening in the lung Cite
Nicolas E, Kosmider B, Cukierman E, Borghaei H, Golemis EA, Borriello L. Cancer treatments as paradoxical catalysts of tumor awakening in the lung. Cancer and Metastasis Reviews. Springer Science and Business Media LLC; 2024; 10.1007/s10555-024-10196-5
Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis Cite
Alkhafaji S, Wolf DM, Magbanua MJM, J. van ‘t Veer L, Park JW, Esserman L, et al. Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis. npj Breast Cancer. Springer Science and Business Media LLC; 2024; 10 10.1038/s41523-024-00623-9
Circulating tumor cells and vitamin D in primary breast cancer. Cite
Mego M, Vlkova B, Karaba M, Minarik G, Benca J, Sedlackova T, et al. Circulating tumor cells and vitamin D in primary breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:e12558-e12558 10.1200/jco.2022.40.16_suppl.e12558
Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis Cite
Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, et al. Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis. npj Breast Cancer. Springer Science and Business Media LLC; 2022; 8 10.1038/s41523-022-00445-7
The metastatic spread of breast cancer accelerates during sleep Cite
Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. Springer Science and Business Media LLC; 2022; 10.1038/s41586-022-04875-y
Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches Cite
Cescon DW, Kalinsky K, Parsons HA, Smith KL, Spears PA, Thomas A, et al. Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches. Frontiers in Oncology. Frontiers Media SA; 2022; 11 10.3389/fonc.2021.667397
Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice Cite
Hamza B, Miller AB, Meier L, Stockslager M, Ng SR, King EM, et al. Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-25917-5
Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells Cite
Wang X, Liu X, Jia Z, Zhang Y, Wang S, Zhang H. Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells. Foods. MDPI AG; 2021; 10:2223 10.3390/foods10092223
In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells Cite
Zhu X, Suo Y, Fu Y, Zhang F, Ding N, Pang K, et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells. Light: Science & Applications. Springer Science and Business Media LLC; 2021; 10 10.1038/s41377-021-00542-5
Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis Cite
Pang S, Jia M, Gao J, Liu X, Guo W, Zhang H. Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis. Life Sciences. Elsevier BV; 2020; 264:118720 10.1016/j.lfs.2020.118720
Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells Cite
Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba BM, et al. Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells. Cell Reports. Elsevier BV; 2020; 32:108105 10.1016/j.celrep.2020.108105
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer Cite
Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, et al. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2020; 6:1410 10.1001/jamaoncol.2020.2295
Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer Cite
Moss J, Zick A, Grinshpun A, Carmon E, Maoz M, Ochana B, et al. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer. Annals of Oncology. Elsevier BV; 2020; 31:395-403 10.1016/j.annonc.2019.11.014
Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery Cite
Li S, Yan W, Yang X, Chen L, Fan L, Liu H, et al. Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-6158-3
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer Cite
Sparano J, O’Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, et al. Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2018; 4:1700 10.1001/jamaoncol.2018.2574
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment Cite
Bauer ECA, Schochter F, Widschwendter P, DeGregorio A, Andergassen U, Friedl TWP, et al. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:571-580 10.1007/s10549-018-4856-1
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis Cite
Bidard F, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, et al. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 110:560-567 10.1093/jnci/djy018
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients Cite
Zhang X, Hofmann S, Rack B, Harbeck N, Jeschke U, Sixou S. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients. International Journal of Molecular Sciences. MDPI AG; 2017; 18:1318 10.3390/ijms18061318
Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer. Cite
Ni C, Yang L. Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e23024-e23024 10.1200/jco.2017.35.15_suppl.e23024
Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells Cite
Anjanappa M, Cardoso A, Cheng L, Mohamad S, Gunawan A, Rice S, et al. Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells. Cancer Research. American Association for Cancer Research (AACR); 2017; 77:2759-2769 10.1158/0008-5472.can-16-3308
Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients Cite
Aktas B, Westerwick D, Mairinger F, Kasimir-Bauer S, Kimmig R, Schmid K, et al. Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients. Poster Session Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-p1-01-09
CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer Cite
Dai M, Zhang C, Ali A, Hong X, Tian J, Lo C, et al. CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep35383
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab Cite
Pierga J, Bidard F, Autret A, Petit T, Andre F, Dalenc F, et al. Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of Oncology. Elsevier BV; 2017; 28:103-109 10.1093/annonc/mdw535
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy Cite
Kasimir-Bauer S, Bittner A, König L, Reiter K, Keller T, Kimmig R, et al. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0679-3
Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients Cite
Zhang S, Li L, Wang T, Bian L, Hu H, Xu C, et al. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2578-5
The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis Cite
Lu Y, Wang P, Wang X, Peng J, Zhu Y, Shen N. The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis. Oncotarget. Impact Journals, LLC; 2016; 7:37361-37369 10.18632/oncotarget.8156
Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice Cite
Donnenberg VS, Huber A, Basse P, Rubin JP, Donnenberg AD. Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice. npj Breast Cancer. Springer Science and Business Media LLC; 2016; 2 10.1038/npjbcancer.2016.4
Abstract P2-02-02: Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer Cite
Janni W, Schramm A, Friedl T, Schochter F, Huober J, Rack B, et al. Abstract P2-02-02: Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p2-02-02
High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation Cite
Huang X, He D, Ming J, He Y, Zhou C, Ren H, et al. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:441-455 10.1007/s10549-016-3696-0
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer Cite
Janni WJ, Rack B, Terstappen LW, Pierga J, Taran F, Fehm T, et al. Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2016; 22:2583-2593 10.1158/1078-0432.ccr-15-1603
Circulating tumor cells in early breast cancer: A connection with vascular invasion Cite
Maltoni R, Fici P, Amadori D, Gallerani G, Cocchi C, Zoli M, et al. Circulating tumor cells in early breast cancer: A connection with vascular invasion. Cancer Letters. Elsevier BV; 2015; 367:43-48 10.1016/j.canlet.2015.06.020
Circulating tumor cells before and during follow-up after breast cancer surgery Cite
VAN DALUM G, VAN DER STAM GJ, TIBBE AG, FRANKEN B, MASTBOOM WJ, VERMES I, et al. Circulating tumor cells before and during follow-up after breast cancer surgery. International Journal of Oncology. Spandidos Publications; 2014; 46:407-413 10.3892/ijo.2014.2694
Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Cite
Babayan A, Hannemann J, Spötter J, Müller V, Pantel K, Joosse SA. Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e75038 10.1371/journal.pone.0075038
Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer Cite
Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, et al. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Medicine. Wiley; 2013; 2:226-233 10.1002/cam4.70
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Cite
Jain S, Cohen J, Ward M, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Annals of Oncology. Elsevier BV; 2013; 24:1491-1498 10.1093/annonc/mds654
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer Cite
Bidard F, Mathiot C, Delaloge S, Brain E, Giachetti S, de Cremoux P, et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Annals of Oncology. Elsevier BV; 2010; 21:729-733 10.1093/annonc/mdp391